Skip to content

Public FDA record

Z-2329-2021: Triathlon Prim CEM FXD BPLT 7, Catalog No. 5520B700

Recall record Z-2329-2021 for Howmedica Osteonics Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2329-2021
Company in FDA record
Howmedica Osteonics Corp.
FDA record creation date
Aug 19, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The internal profile of the Triathlon Prim (Baseplate) is potentially oversized; there may be a witness mark (taper) at the bottom of the internal profile of the baseplate, which prevents the insert from locking on the baseplate.

Source facts

Action
On July 1, 2021, the firm notified customers via Urgent Medical Device Recall. The letter listed the hazards and harms potentially associated with the recalled product and also listed mitigation factors. Patients treated with an affected product should continue to be followed per the normal protocol established by his or her surgeon(s). There are no recommended changes to the frequency of the standard follow-up care protocol. It should be noted that the failure of the insert to fully seat, may not be evident on x-ray unless the insert has dislodged. Actions Needed: Our records indicate that you may have received the affected product(s). It is Strykers responsibility as the manufacturer to ensure that customers who may have received these affected products also receive this important follow up communication. We therefore request that you read this notice carefully and complete the following actions. 1. Please inform users of this Urgent Medical Device Recall and forward this notice to all individuals who need to be made aware. 2. Immediately check all stock areas and/or operating room storage to determine if any devices from the affected product list are at your facility. 3. Quarantine and discontinue use of the recalled devices identified in the affected product list. Return the devices back to Stryker. Customers should complete and sign the included customer response form and return it to the recalling firm. Hospitals should contact their local sales office or Stryker sales representative directly for product returns and inventory questions. Customers who have further distributed the product should forward should notify downstream accounts and return all affected devices to the recalling firm. For questions pertaining to the recall, please contact Customer Service at (201) 831-5000, or email SO_M_PRODUCT_FIELD_ACTION_RESPONSE@stryker.com
Initiated
2021-07-01
Root cause
Under Investigation by firm
Terminated
2023-05-17
Distribution
Worldwide distribution - US Nationwide distribution in the states AR, CO, MN, MS, NJ, OK, PA, TX and the countries of China and Italy.
Recall number
Z-2329-2021
Recall status
Terminated
CDRH record ID
188610
FDA record created
2021-08-19
Recall event number
88422

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗